Global Tuberculosis (TB) Diagnostics Market 2017-2021

結核(TB)診断の世界市場2017-2021

◆タイトル:Global Tuberculosis (TB) Diagnostics Market 2017-2021
◆商品コード:IRTNTR15492
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年11月2日
◆ページ数:91
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、結核(TB)診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、結核(TB)診断の世界市場規模及び予測、製品別分析、需要先別分析、主要国別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社は結核(TB)診断の世界市場が2017-2021年期間中に年平均3.56%成長すると予測しています。当レポート上に記載されている主な企業は、Abbott、BD、bioMérieux、F. Hoffmann-La Roche、Thermo Fisher Scientific等です。

・エグゼクティブサマリー
・結核(TB)診断の世界市場:市場概観
・結核(TB)診断の世界市場:業界の構造分析
・結核(TB)診断の世界市場:市場規模及び予測
・結核(TB)診断の世界市場:製品別分析
・結核(TB)診断の世界市場:需要先別分析
・結核(TB)診断の世界市場:アジア市場規模
・結核(TB)診断の世界市場:アメリカ市場規模
・結核(TB)診断の世界市場:ヨーロッパ市場規模
・結核(TB)診断の世界市場:主要国別分析
・結核(TB)診断の世界市場:成長要因
・結核(TB)診断の世界市場:課題
・結核(TB)診断の世界市場:市場動向
・結核(TB)診断の世界市場:競争状況
・結核(TB)診断の世界市場:主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About Tuberculosis (TB) Diagnostics
TB is a contagious infection that usually attacks the lungs. It may also spread to other parts of the body such as the brain and the spine. TB commonly spreads through the air when an infected person coughs, sneezes, spits, laughs, or talks. Mycobacterium tuberculosis is responsible for the onset of the disease. In the 20th century, TB was a leading cause of death. However, today, most cases are cured with antibiotics, which is a time-consuming process. Medicines should be taken for at least six to nine months.

Technavio’s analysts forecast the global tuberculosis (TB) diagnostics market to grow at a CAGR of 3.56% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global tuberculosis (TB) diagnostics market for 2017-2021. To calculate the market size, the report considers the new installations, shipments, sales, volume, and value.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Tuberculosis (TB) Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott
• BD
• bioMérieux
• F. Hoffmann-La Roche
• Thermo Fisher Scientific

[Other prominent vendors]
• Akonni Biosystems
• Ameritek USA
• Autobio Diagnostics
• Cepheid
• EIKEN CHEMICAL
• GeTein BioMedical
• Hain Lifescience
• Hologic
• NanoEnTek
• Ortho Clinical Diagnostics
• QIAGEN
• Siemens Healthineers

[Market driver]
• Increasing prevalence of TB
• For a full, detailed list, view our report

[Market challenge]
• Accessibility and cost constraints of advanced TB diagnostics
• For a full, detailed list, view our report

[Market trend]
• Expansion of healthcare infrastructure
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
• Overview

PART 05: MARKET LANDSCAPE
• Overview
• Market size and forecast
• Five forces analysis

PART 06: SEGMENTATION BY PRODUCT TYPE
• Overview
• Culture
• Mantoux tuberculin test
• Molecular testing
• Smear microscopy
• LF-LAM for PLHIV
• Drug susceptibility testing

PART 07: SEGMENTATION BY END-USER
• Overview
• Hospitals
• Diagnostic laboratories

PART 08: SEGMENTATION BY GEOGRAPHY
• Overview
• Regional comparison
• APAC
• Americas
• EMEA
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 11: MARKET TRENDS
• Focus on partnerships and acquisitions for product development
• Continuous technological advances
• Expansion of healthcare infrastructure

PART 12: VENDOR LANDSCAPE
• Competitive landscape

PART 13: KEY VENDOR ANALYSIS
• Abbott
• BD
• bioMérieux
• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• Other prominent vendors

PART 14: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Share of global TB diagnostics market of global IVD market 2016 (%)
Exhibit 02: Global TB diagnostics market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global TB diagnostics market: Segmentation by product type 2016 (% share)
Exhibit 05: Global TB diagnostics market: Segmentation by end-user 2016 (% share)
Exhibit 06: Global TB diagnostics market by hospitals 2016-2021 ($ billions)
Exhibit 07: Global TB diagnostics market by hospitals: Year-over-year growth 2017-2021 (%)
Exhibit 08: Global TB diagnostic market by diagnostic laboratories 2016-2021 ($ billions)
Exhibit 09: Global TB diagnostics market by diagnostic laboratories: Year-over-year growth 2017-2021 (%)
Exhibit 10: Global TB diagnostics market: Segmentation by geography 2016-2021 (% share)
Exhibit 11: Global TB diagnostics market: Regional comparison
Exhibit 12: TB diagnostics market in APAC: Overview
Exhibit 13: TB diagnostics market in APAC 2016-2021 ($ billions)
Exhibit 14: TB diagnostics market in APAC: Year-over-year growth 2017-2021 (%)
Exhibit 15: TB diagnostics market in Americas: Overview
Exhibit 16: TB diagnostics market in Americas 2016-2021 ($ billions)
Exhibit 17: TB diagnostics market in Americas: Year-over-year growth 2017-2021 (%)
Exhibit 18: TB diagnostics market in EMEA: Overview
Exhibit 19: TB diagnostics market in EMEA 2016-2021 ($ billions)
Exhibit 20: TB diagnostics market in EMEA: Year-over-year growth 2017-2021 (%)
Exhibit 21: Global TB diagnostics market: Key leading countries
Exhibit 22: Global TB diagnostics market: Competitive structure analysis 2016
Exhibit 23: Abbott: Key highlights
Exhibit 24: Abbott: Strength assessment
Exhibit 25: Abbott: Strategy assessment
Exhibit 26: Abbott: Opportunity assessment
Exhibit 27: BD: Key highlights
Exhibit 28: BD: Strength assessment
Exhibit 29: BD: Strategy assessment
Exhibit 30: BD: Opportunity assessment
Exhibit 31: bioMérieux: Key highlights
Exhibit 32: bioMérieux: Strength assessment
Exhibit 33: bioMérieux: Strategy assessment
Exhibit 34: bioMérieux: Opportunity assessment
Exhibit 35: F. Hoffmann-La Roche: Key highlights
Exhibit 36: F. Hoffmann-La Roche: Strength assessment
Exhibit 37: F. Hoffmann-La Roche: Strategy assessment
Exhibit 38: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 39: Thermo Fisher Scientific: Key highlights
Exhibit 40: Thermo Fisher Scientific: Strength assessment
Exhibit 41: Thermo Fisher Scientific: Strategy assessment
Exhibit 42: Thermo Fisher Scientific: Opportunity assessment



【掲載企業】

Abbott, BD, bioMérieux, F. Hoffmann-La Roche, Thermo Fisher Scientific, Akonni Biosystems, Ameritek USA, Autobio Diagnostics, Cepheid, EIKEN CHEMICAL, GeTein BioMedical, Hain Lifescience, Hologic, NanoEnTek, Ortho Clinical Diagnostics, QIAGEN, and Siemens Healthineers.


【資料のキーワード】

結核診断、結核検査、医療

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[結核(TB)診断の世界市場2017-2021]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆